Prospective Study of Palonosetron in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting (RINV) - a Phase II Study
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 05 Oct 2017 Status changed from recruiting to completed.
- 24 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2017.
- 14 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.